2MO XPO1 inhibition strongly sensitizes to first-line and second-line therapy in small cell lung cancer
Titel:
2MO XPO1 inhibition strongly sensitizes to first-line and second-line therapy in small cell lung cancer
Auteur:
Quintanal-Villalonga, Á. Taniguchi, H. Hao, Y. Chow, A. Zhan, Y.A. Uddin, F. Allaj, V. Manoj, P. Shah, N. Chan, J.M. Offin, M. Ciampricotti, M. Egger, J. Qiu, J. De Stanchina, E. Hollmann, T.J. Koche, R.P. Sen, T. Poirier, J.T. Rudin, C.M.